相关实验视频
Updated: Jun 12, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.4K
在患有帕金森病的人群中远程传递语音疗法的有效性 - 一项随机对照试验
Janna J L Maas1, Nienke M de Vries1, Joanna IntHout2
1Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, the Netherlands.
EClinicalMedicine
|September 23, 2024
概括
远程语音治疗改善了帕金森病患者的沟通生活质量. 这种个性化的方法为内部治疗提供了更容易获得的替代方案,提高了患者的幸福感.
科学领域:
- 神经学 神经学
- 语音语言病理学 语言病理学
- 康复医学 康复医学 康复医学
背景情况:
- 帕金森病 (PD) 通常需要语音治疗,但内部治疗对患者来说存在重大后勤挑战.
- 远程,个性化语言治疗提供了潜在的更容易获得和更有效的干预.
- 展望研究调查了PD患者远程语音治疗的疗效.
研究的目的:
- 评估远程交付,个性化言语治疗在改善帕金森病患者生活质量和言语的有效性.
- 将远程语音治疗与无干预对照组进行比较.
主要方法:
- 一个单盲,随机对照试验 (RCT) 涉及214名语音理解能力低下的参与者.
- 参与者被随机分配到一个为期8周的个性化远程语音治疗计划或等候名单对照组.
- 结果,包括帕金森病问卷39 (PDQ-39),在基线,8周和32周评估.
主要成果:
- 干预组在PDQ-39的通信指数得分上显示了统计学上显著的改善 (p=0.011).
- 虽然PDQ-39总体得分在8周后没有达到统计学意义 (p=0.056),但在32周后的随访显示出显著的改善 (p=0.004).
- 在其他PDQ-39域中,在8周后的组之间没有观察到显著差异.
结论:
- 个性化远程语音治疗有效地提高了帕金森病患者的与沟通相关的生活质量.
- 这种方法为传统的内部语音治疗提供了可行的和可访问的替代方案.
- 进一步的研究可能会探索长期影响和更广泛的生活质量影响.
相关概念视频
Parkinson's Disease: Treatment
235
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235
Parkinson's Disease: Overview
495
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495

